HSU77604, GENBANK, Sep. 29, 1997.* |
Forsberg et al., “Oxidative Stress, Human Genetic Variation, and Disease”, Archives of Biochemisty and Biophysics vol. 389 No. 1 May 1, 2001 pp. 84-93.* |
Scoggan et al., “production of Leukoriene C4 in Different Human Tissues Is Attributable to Distinct Membrane Bound Biosynthetic Enzmes”, J. of Biological Chemistry (1997) vol. 272 No. 15 pp. 10182-10187.* |
H. Raunio, et al.: “Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptiblility—a reviw”; Gene, Elsevier Biomedical Press, Amsterdam, NL. vol. 159, No. 1; Jun. 14, 1995, pp. 113-121, XP004042243; ISSN: 0378-1119. |
M. Sanak, et al.; “leukotriene C4 synthase promotor polymophism and risk of aspirin-induced asthma”; The Lancet, Lancet Limited; London, GB; vol. 350, Nov. 29, 1997; pp. 1599-1600; XP002086063; ISSN 0140-6736. |
Anderson M.E., “Glutathione and Glutathione Delivery Compounds”, Advances in Pharmacology, 38: 65-74, 1997. |
Jakobsson, P.J., et al., “Identification and Characterization of a Novel Human Microsomal Glutathione S-Transferase with Leukotriene C4 Synthese Activity and Significant Identity to 5-Lipoxygenase-Activating Protein and Leukotriene C4 Synthase”, Journal of Biological Chemistry, 271:22203-22210, 1996. |
Petric, R., et al., “Renal Leukotriene C4 Synthase: Characterization, Partial Purification and Alterations in Experimental Glomerulonephritis”, Biochim. Biophys. Acta, 1254:207-215, 1995. |
Stenke, L., et al., “Increased Leukotriene C4 Production in Chronic Myelogenous Leukemia”, Acta Oncologica, 27:803-805, 1987. |